Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
51
NAMS Quote, Financials, Valuation and Earnings
Last price:
$35.47
Seasonality move
:
-4.57%
Day range:
$33.24 - $35.00
52-week range:
$14.06 - $42.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
178.26x
P/B ratio:
5.77x
Volume:
900.9K
Avg. volume:
676K
1-year change:
73.92%
Market cap:
$3.9B
Revenue:
$22.5M
EPS (TTM):
-$1.75
Earnings Data
Next earnings date for NAMS
May 07
2026
Most recent earnings per share
-$0.65
Missed by $0.22
(Feb 18/2026)
Consensus Estimate
-$0.43
(Feb 18/2026)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NAMS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/07/2026 | Q1 | $1.2M | -- | -- | -$0.51 | -- |
| 02/18/2026 | Q4 | $2.9M | $32K | -$0.65 | -$0.43 | -$0.22 |
| 11/05/2025 | Q3 | $5.2M | $348K | -$0.61 | -$0.40 | -$0.20 |
| 08/06/2025 | Q2 | $1.8M | $19.1M | -$0.15 | -$0.49 | $0.35 |
| 05/08/2025 | Q1 | $1.6M | $3M | -$0.34 | -$0.49 | $0.15 |
| 02/26/2025 | Q4 | $1.8M | $12.8M | -$0.95 | -$0.49 | -$0.46 |
| 11/06/2024 | Q3 | $1.8M | $29.1M | -$0.18 | -$0.49 | $0.31 |
| 08/07/2024 | Q2 | $1.2M | $2.3M | -$0.41 | -$0.57 | $0.15 |
| 05/09/2024 | Q1 | $1.7M | $1.4M | -$1.06 | -$0.52 | -$0.54 |
| 02/28/2024 | Q4 | $1.9M | -- | -- | -$0.59 | -- |
| 11/13/2023 | Q3 | -- | -- | -- | -$0.52 | -- |
| 08/07/2023 | Q2 | $2.1M | -- | -- | -$0.47 | -- |
| 05/08/2023 | Q1 | -- | -- | -$0.51 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -- | -$0.43 | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.27 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.07 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | $0.08 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | $0.05 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | $0.10 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.07 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | $0.16 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | $0.00 | -- | -- |
NewAmsterdam Pharma Co. NV Earnings Questions
-
How Much did NewAmsterdam Pharma Co. NV Generate in Revenue Last Quarter?
NewAmsterdam Pharma Co. NV reported $32K worth of top line sales in its most recent quarter.
-
Did NewAmsterdam Pharma Co. NV Beat Earnings Last Quarter?
NewAmsterdam Pharma Co. NV announced earnings per share of -$0.65 which represents a miss of analyst forecast a -$0.43 per share.
-
Is NewAmsterdam Pharma Co. NV Profitable?
NewAmsterdam Pharma Co. NV reported -$27K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for NewAmsterdam Pharma Co. NV EPS Next Year?
NewAmsterdam Pharma Co. NV's earnings are forecast to decrease from -$1.72 per share to -$1.57 per share next year representing a decrease of -16.24%.
-
When is NewAmsterdam Pharma Co. NV's Earnings Date?
NewAmsterdam Pharma Co. NV's next earnings date is May 7, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 38x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
37
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
59
SEZL alert for Feb 27
Sezzle, Inc. [SEZL] is down 13.92% over the past day.
Buy
83
GCT alert for Feb 27
GigaCloud Technology, Inc. [GCT] is down 5.87% over the past day.
Buy
62
LMAT alert for Feb 27
LeMaitre Vascular, Inc. [LMAT] is down 4.76% over the past day.
